Charity registration number 1084898
SYNCOPE TRUST AND REFLLX ANOXIC SEIZURES
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
LEGALAND ADMINISTRATIVE INFORMATION
Trustees
Dr. W P Whitehou5e
Mrs C L Reid
E Bateson
Dr M Asgari
Charbty number
1084898
Princlpal address
TC Group
Celixir House
Straford Business & Technology Park
Innovation Way, Banbury Road
Strarford~upon-Avon
Warwick5hire
CV37 7GZ
Independent examiner
TC Group
Celixir House
Stratford Business & Technology Park
Innovation Way, Banbury Road
Stratford-upon-Avon
Warwick5hire
United Kingdom
CV37 7GZ

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
CONTENTS
Page
Trustees, report
Independent examiner's report
Statement of financial activities
Balance sheet
Notes to the fi.nancial statements
10.17

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
TRUSTEES, REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
The Trustees present their annu31 report and financial statements for the year ended 31 December 2024.
The financial statements have been prepared in accordance with the accounting politles set out in notè I to the
financial statements and comply with the Charity's Igoverning document], the Charities Act 2011 and "Accounting
and Reporting by Charities.. Statement of Recommended Practice applicable to charities preparing their accounts
in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FPS
1021" (effective l January 20191.
Objeetives and artivitie5
The principal objective5 of the charity are..
To alleviate the effects of and provide support and information on, syncope and reflex 2nDxic seizures, to those in
distress as a result of these sèilures. whether suffered by themselve5 or as a member of the family group.
To advance the education of the medical profession and the general public on the subject of syncope and reflex
anoxic seizures and its implication5 for the individual and family.
To promote research into the management of syncope and reflex anoxic seizure and to publish the U￿ful results
thereof and to support organisations promoting research into syncope and reflex seizures.
There have been no changes to these objettives since the last annual report.
Volunteers
STARS utilises volunteers to a55i5t in our work.
STARS Trustees review the aims, objective5 and the activities of the Charity each yèar. This report looks at what the
Charity has achieved and the outcomes of its activities in the reporting period, January to December 2024. The
review also helps to ensure that the Charity's aims, objectives and activities remain focused on it5 Stated
purposes.
There is no such thing as a simplefoint,. Syncope is a symptom not o condition,. take fainting to heart. Quotes that
are synonymous with the campaign5 STARS has run over the years and which have been instrumental in raising
awareness and reducing misdiagnosis.
Our vision is that every patient with syncope received a corrett diagnosis and treatment.
Our mi55ion is working together to improve the dlagnosis, treatment and quality of life for all tPose affetted by
syncope. This year STARS celebrates its, 31st anniversary.
Public benefit
The Trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the
Charity should undertake. The trustees confi'rm that they have complied with their duty under SeLtion 4 of the
Charitie5 Art 2011 to have due regard to the Charity Commission's general guidance on public benefit.

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
TRUSTEES. REPORT (CONTINUED
FOR THE YEAR ENDED 31 DECEMBER 2024
Achievements and perfomiance
Significant uctivities and achievements ugainst objectives
STARS continues to be the only organisation globally dedicated to providing information, support, education and
awareness on unexplained loss of consciousness, syncope, reflex anoxic seizures, POTS and related conditions.
We are freq¢Jently requested to present at medical meetings, provide answers to schools about how to receive a
child with RAS and to provide the necessary support to p3rent5, caregivers, and familie5 to help them better
support the person living with the condition.
Professor John B P Stephenson
STARS Founding Patron, Professor John B P stephenson sadly passed away on 17 April 2024. The Charity is
immensely grateful for all the support and commttment he provided over more than 30 years.
It wa5 1978 when Prof Stephenson gave a name to the unexplained loss of consciousness young chlldren were
experiencing. Reflex Anoxic Seizure5 IRASI. Until then, many children were being misdiagnosed with epilepsy and
prescribed what would have been unnecessary anti-epilepb"c medication. It was Prof Stephenson who then asked
whether we would like to start a small 'support group to help about ten families a year,. This was March 1993,
and STARS was conceived.
In 1994, he presented at the very first STARS Patrent Day. attended by 106 adults and 98 children. The children,
some of whom artually had an RAS éttack on the day, were looked after In five creches by qualified Kilunteers.
The Professor thought this was marvellous as it helped with his research. He was already becoming
internationally recognised as a pioneer in paediatric neurology and until last year had published numerous papers
and books.
He kept his promise he made in 1993 to support STARS; he attended every patient day for the next 20 years and
more and presented at the Heart Rhythm Congress. He also made a surprise entrance at the Palace ol
Westminster for STARS 25" anniversary. He was very proud of STARS and all that we have achieved.
He had a vision na child would be misdiagnosed with epilepsy as long as RAS was recognised and un(krstood by
the medical profession. STARS will continue to SLtpport his work and ensure it has not been in vain.

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
TRUSTEES, REPORT ICONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
Supportiftg people living with Syncope, RAS and POTS
STARS educational videos, resources, online forums and other information continue to deliver information,
SUPPOrt, education, and awareness to all those affected by syncope and loss of consciousness. Webinars were
produced with guidance and contributions from healthcare professionals, ensuring our material is up to date and
informative for VARS audience. Over 109,000 individual views during 2024. A new RAS Discussion Guide wa5 also
developed during the year.
Virtual coffee mornings
An opportunity to talk to patients, caregivers and family members sharing experiences, and where the STAR5 team
can provide reassurance and guid3nce. DurinE 2024 STARS online meetings included topics such as-
RAS- StartinE School and College held on the 04 July 2024
Llving with RAS and Syncope- STARS continued throughout 2024 with its 'Living With...
series for patient video
education on a range of subjetts which includes Living with RAS and Syncope. All of these are avail able online and
are free to register to watch.
Ralsing awareness of syncope and syncope-related conditions - World Heart Rhythm Weèk 2024
STARS collaborates and supports the World Heart Rhythm Week hosted in June each year and organised by its
sister charity- Arihythmia Alliance.
For WHRW2024 the theme was 'Act Smart, You Only Have One Heart'l Supporters were encouraged to rase
awareness of syncope, highlighting that syncope is often overlooked, but it can be a warning sign of an underlying
heart rhythm disorder. Early detection and proper diagnosis are key to preventing serious complications, and
during the week STARS was able to ensure more people were aware of syncope as a potential symptom of an
irregular heart rhythm, to seek medical advice if they or a loved one experienced
nexplained 1055 of consciousness or have a history of Sudden cardiac death in the family, and to access STAR5
resources.
We received support from thousands of individuals, organi5ations, and healthcare professional around the globe,
resulting in Dur campaign reaching many millions of people.

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
TRUSTEES. REPORT (CONTINUED
FOR THE YEAR ENDED 31 DECEMBER 2024
Hostln8 events for both healthcare professionalsi patients, and caregiver5.
STARS Patiertts Educational Day was held as part of the annu31 Heart Rhythm Congress èt the ICC in Birmingham.
The day was well attended and, sessions included presentstion5 on the variou5 concerns relating to Situational
Syncope, RAS /Syncope in the young, Cardiac Syncope, Complexity of Syncope in the elderly, and TiltTable resting.
There w35 a live patient story which also included the opportunity for question5 and answers. All sessions were
recorded and hosted online 50 those who could not attend in person could still access thi5 informati)n. Thi5
enables access throughout the year to all patients and care givers.
STARS Patients Day provides the opportunity to hear the latest developments in syncope, and treatment options,
from leading medical experts from the UK, USA, Canada, Europe and Monaco.
STARS Symposla for healthcare professionals w35 hosted during the Heart Rhythm Congre55. Subjects covered
were.. -
Syncope: Driving and flyin& Syncope in the Workplace, Syncope.. Reaplife diagnostic tests in a modern syncope
unit, Syncope in the emergency department, Syncope and genetic arrhythmias and Syncope epidemiology and
natural history. Presented by speakers from Europe. Canada- Monaco; UK & USA.
Resources
New publications for 2024 include a RAS discussion guide which is availa ble online and in paper format. With a full
listing of publications also available on our website www.stars.orE.uk
Fundraislng
During the current etonomic situ2tr.on STARS ha5 received significantly reducèd donations however we did see
many more funéraisers during 2024 through JustGiving, adding a boost to our fund5. Monthly amounts were
raised through lending of books organised by a STARS Trustee, and a Dr based in Glasgow raised money for STARS
by cycling from Lands, End to John O Groats.
STARS Helplifte
STARS has received even more enquirie5 during 2024- the demand increases year on year, and we wlll continue to
meet this demand and work to reduce the struggle to find an appropriate healthcare professional to diagnose
correttly and to reduce the number of misdiagnoses for people living with these conditions.
STARS continues to meet demand from patients, Caregivers, families, schools, colleges and universities, work
environments and care homes plus healthcare profession315 and clinics seeking information. education, support
and greater awareness. We plan for future years to be as successful as the previoL¢S 31 years and live in hope that
a5 awareness increases $0 too will detection and diagnosis leading to better outcomes for all those impacted by
these conditions. We must also focus on ensuring no matter where someone lives, they can access a service near
to them. Currently with so few dedicated clinic5 It is a challenge for so many to find an expert Itxally.
Communicating our work
Effective communications are key to sharing the work that the Charity undertakes. RaisinB awareness of our
website resources, and our use of social media are vital to gr¢wing patier)t Èngagement and awareness of syncope
and unexplained loss of consclousness.

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
TRUSTEES. REPORT (CONTINUED}
FOR THE YEAR ENDED 31 DECEMBER 2024
Flnancial review
The Charity has seen a decrease in income from £121,559 in 2023 to £106,975 in 2024. This 15 due to a decrease in
donation income from £17.239 in 2023 to £14,068 in 2024 and a decrease in grant income from £103,667 in 2023
to £89,674 in 2024.
Expenditure decreased from £79,302 in 2023 to £76,145 in 2024. The Charity's total funds increased by £30,830 to
£636,150 in the financial year.
The Trustee5 have a strategic and operational plan in place to ensure stability and growth,
Reserve5 policy
The Trustees have a policy of maintaining a level of unrestricted reserves which should ensure that there are
adequate funds to meet anticipated future liabilities. In practice the Trustees consider that holding reserves
equivalent to a minimum of 3 month5, core costs. excluding funds tied up in fixed assets should provide sufficient
funds to respond to unexpected adverse changes in the Charity's funding or activities. This equates to a minimum
of £15,000 based on the current leve15 of activity. The Trustees consider that the current level of unrestricted
reserves is therefore adequate.
Structure, governance and management
Governing document
The Charity is constituted under a Charity Commission Scheme and is registered Charity number 1084898. The
Charity's activities are governed by a Declaration of Trust adopted on 24 November 2000. The Charity was granted
charitable status on 6 February 2001.
The Trustees who served during the year and up to the date of signature of the financial statement5 were..
Dr. W P Whitehouse
Mrs CL Reid
E Bateson
Dr M Asgari
Recruitment and appointment of trustee5
The management of the Charity is responsible of the Trustee5 who are elected and ctiopted under the term5 of
the Trust deed. There must at all times be a minimum Df three Trustees in office. The first Trustees are entitled to
hold office for life. New frustees are appointed by a re501ution passed by the TrL¢Stees in special meeting.
Orgt7nisationol Structure
The Trustees delegate the day to day management of the Charity to the Chief Executive and her support 5t3ff.
Induction and training of trustees
New Trustee5 undergo an orientation process to brief them on their legal obligations under Charity law the
Charity's governing documents, the committee and decision making process, the business plan and reC￿t
financial performance of the Charity. During the induction process they meet key employees and other trustees.
Trustees are encouraged to attend appropriate external and internal training events which will asslst them in
carrying out their role.

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
TRUSTEES, REPORT (CONTINUED
FOR THE YEAR ENDED 31 DECEMBER 2024
Ackn<Jwledgements
STARS would like to acknowledge the various Trusts. Foundations and Medical Industry that 50 generously gave
their support during the financial year.
The Trustees would like to recognise the outstanding contribution made by Trudie Lobban in pursuit of sfARS goals
and the significant and high impact achievements attained this year through her vision and determinatton. The
Trustees would also like to acknowledge the commitment of the STARS team in their empathetic approach to the
dellvery of STARS service throughout the year.
Conntcted Charities
Arrhythmia Alliance IAAI, a UK registered Charity, number 1107496 15 connected to STARS as an affiliate of the
umbrella organisation.
Atrial Fibrillation Association {AFAI, a UK registered charity, number 1122442 is connected to STARS 35 an affi'liate
of the umbrella organisation.
STARS US, Inc, a registered SOI{cl non profit organisation in the USA is connected to AFA as an affiliate of the
umbrella organi5ation.
The Trustee5' report was approved by the Board of Trustees.
Mrsc LReid
Tru5teÉ
20 August 2025

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
I report to the Trustees on my examlnatfon of the financial statements of Syncope Trust and RefiexAnoxic Seizures
(the Charityl for the year ended 31 December 2024.
Responslbilities and basls of report
As the Tru5tee5 of the Charity you are responsible for the preparation of the financial statements in accordance
with the requirements of the Charities Art 2011 Ithe 2011 Act).
I report in respect of my examlnation of the Charity'5 financial statements carried out under section 145 of the
2011 Act. In carrying out my examination I have followed all the applicable Directions given by the Charity
Commission under section 14515)Ibl of the 2011 Act,
Independent examiner's statement
Your attention is drawn to the fact that the charlty has prepared financial statements in accordance with
Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting
Standard applicable in the U K and Republic of Ireland IFRS 1021 in preference to the Accounttng and Reporting bv
Charitie5.' Statement of Recommended Practice issued on l April 2005 which is referred to in the eXt￿t
regulations but has now been withdrawn.
understsnd that this has been done in order for flnancial statements to provide a true and fair view in
accordance with Generally Accepted Accounting Practice effective for reporting periods beginning on or after I
January 2015.
I have completed my examinatr"on. I confirm that no matters have come to my attention in connection with the
examination giving me cause to believe that in any material respect..
accounting records were not kept in respect of the Charity as required by sectfon 130 of the 2011 Act,. or
the financial statements do not accord with those records,. or
the financial statements do not comply with the applicable requirements concerning the fomi and content of
accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that
the account5 give a true and fair view which is not a matter considered a5 Part of an independent
examination.
I have no concerns and have come across no other matters in connection with the examination to whth attention
should be drawn in this report in order to enable a proper understanding of the financial statements to be
reached.
TC Group
Celixir House
Stratford Business & Technology Park
Innovation Way, Banbury Road
Strarford-upon-Avon
Warwickshire
CV37 7GZ
United Kingdom
Dated: 20 August 2025

SYNCOPE TRusf AND REFLEX ANOXIC SEIZURES
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2024
Unre5trlcted
funds
2024
Unrestrlcted
funds
2023
Notes
Income from:
Donations and legacies
Charitable activities
Investments
14,068
89,674
3,233
17,239
103,667
653
Total income
106,975
121,559
Expenditure on:
Charitable attivities
76,145
79,302
Total expendlture
76,145
79,302
Net income and movement in funds
30,830
42,257
Reconciliation of funds:
Fund balances at l January 2024
605,320
563,063
Fund balances at 31 December 2024
636,150
605,320
The ststement of financial activities includes all gains and losses recognised in the year. All income and
expenditure derive from continuin£ attlvities.

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
BALANCE SHEET
AS AT 31 DECEMBER 2024
2024
2023
Notes
Current assets
Debtors
Cash at bank and in hand
13
79,328
560,28Q
540,379
68,597
639,608
608,976
Creditors: amounts falling due withln one
year
14
13,4581
13,6561
Net current assets
636,150
605,320
Net assets excluding penslon Ilabllity
636,150
605.320
The funds of the Charity
Unrestricted funds
636,150
605,320
636,150
605,320
The financial statements were approved by the Trustees on 20 August 2025
Mrs C L Reid
Trustee

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
Accounting policie5
Charlty information
Syncope Trust and Reflex Anoxic Seizures is a unincorporated Chèrity.
1.1 Accounting eonventlon
The financial statements have been prepared in accordance with the Charity's Igoverning documentl, the
Charities Act 2011, FRS ID2 "The Financial Reporting Standard applicable in the UK and Republic of
Ireland" I'FRS 102.1 and the Charities SORP "Accounting and Reporting by Charitie5'. Statement of
Recommended Practice appSicable to charities preparing their accounts in accordance with the Financral
Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021" (effective l January 20191. The
Charity is a Public Benefit Entity a5 detined by FRS 102.
The Charity has taken advantage of the provisions in the SORP for rharities not to prepare a State ment of
Cash Flows.
The ftnancial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to
the extent required to provide a true and f31r view. This departure has involved following the Statement of
Recommended Practrce for charities applying FRS 102 rather than the version of the Statement of
Recommended Practice which is referred to in the Regulatr"ons but which has since been withdrawn.
The financial statements are prepared in sterling, which is the functional currency of the Charity. Monetary
amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal aoounting
policies adopted are set out beS0w.
1.2 Going concern
At the time Df approving the finaF)cial statement5, the Trustees have a reasonable expectation that the
Charity ha5 adequate resources to continue in oper2tr.onal existence for the foreseeable future. Thus the
Trustees continue to adopt the going concern basis of accounting in preparing the financi31 statements,
1.3 Charitsble funds
Unrestricted funds are available for USÈ at the discretion of the Trustee5 in furtherance of their charitable
objectives.
Restricted funds are subjed to specific conditions by donors or grantors as to how they may be used. The
purposes and uses of the restricted funds are set out in the notes to the financial statements.
1.4 Income
Income is recognised when the Charity is legally entitled to it after any performance conditions have been
met, the amounts can be measured reliably, and it is probable that income will be received.
Cash donatr'ons are reco8nised on receipt. Other donation5 are recognised once the Charity ha5 been
notified of the donation, unless performance conditr'ons require deferral of the amount. Income tax
recoverable in relation to donations received under Gift Aid or deeds of covenant 15 recognised at the time of
the donation.
10-

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR EfiIDED 31 DECEMBER 2024
A¢¢ountlng poll¢les
Icontintsed)
Legacies are recognised on receipt or otherwise if the Charity has been notified of an Impending
distribution. the amount is known, and receipt is expected. If the amount is not known. the legacy s treated
a5 a contingent asset.
1.5 Expenditure
Expenditure is recognised once there 15 a legal or constructive obli6ation to transfer economic bwefit to a
third party, it is prob3ble that a transfer of economic benefits will be required in settlement. andthe amount
of the obligation can be measured reliably.
Expenditure is classtfi'ed by activity. The costs of each activity are made up of the total of dirert cost5 and
shared costs, including 5UPPOrt C05ts involved in undertaking each activity. Direct costs attributaEAe to a
single activity are allocated directly to that activity. Shared cost5 which contribute to more than one 3ctivity
and support costs which are not attributable to a single activity are apportioned between those actwitie5 on
a basts consistent with the use of resources. Central staff costs are allocated on the basis of time spent. and
depreciation charges are allocated on the portion of the as5et'S Use.
1.6 Tangible fixed èssets
Tangible fixed assets are initially measured at C05t and subsequently measured at CQ5t or valuation. net of
depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of a55ets less their residual value5 over
their useful lives cn the following bases..
Fixtures and fittings
50% striaght line
The gain or loss arising on the disposal of an 25set is determined as the difference between the sale
proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.
1.7 Cash and cash equivalents
Cash and cash equivalents include cash in hand. deposits held at call with banks, other short-term liquid
investments WFth original maturities of three months or less. and bank overdrafts. Bank overdrafts are
Shown within borrowings in current Ilabilities,
1.8 Financial instruments
The Charity has elected to apply the provi5i0ns of Section 11 'Basic Financial Instruments, and Section 12
'Other Financial Instruments Issues, of FRS 102 to 311 of its financial instruments.
Financial instruments are reco8nised in the Charity's balance sheet when the Charity becomes party to the
contractual provisions of the instrument,
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when
there is a legally enforceable right to set off the recognised amounts and there 15 an intention tosettle on a
net ba515 or to realise the asset and settle the liébility simultaneously.
11

SYNCOPE TRusf AND REFLEX ANOXIC SEIZURES
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
Accounting polictes
{Continuedl
Basicfinonclal assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured *
transaction price including transaction costs and are subsequently carried at amortised cost using the
effective interest method unless the arrangement constitutes a fi'nancing transaction, where the transaction
is measured at the present value of the future receipts discounted 3t a market rate of interest. Financial
assets c1855ified a5 receivable within one year are not amortised.
Ba5icfinancial Iltsbilitles
Basic financial liabilities, including creditor5 and bank loan5 are initially recognised at transaction price unless
the arrangement constitutes a financing transaction, where the debt instrument ¢5 measured at the prpsent
value of the future payments discounted at a market rate of interest. Financial liabilities classifi'ed as payable
within one year are not amortised.
Debt instruments are subsequently carried at amortised CDSt, using the effective interest rate method.
Trade creditor5 are obligation5 to pay for goods or servites that have been acquired in the ordinary course of
operations from suppliers. Amounts payable are classified as current liabilities if p3yment is due within one
year or less. If not, they are presented as non-current liabilities. Tr3de creditors are recognised initially at
transattion price and subsequently measured at amortised c05t using the effective interest method.
Derecognition offinonclal liabilities
Financial liabilities are derecognised when the Chariws contractual obligations expire or are discharged or
cancelled.
1.9 Employee benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee's services are
received.
Termination benefits arÈ rècognised immediately as an expense when the Charity is demonstrablv
committed to terminate the employment of an employee or to provide termination benefi'ts,
1.10 Retirement benefTts
Payments to detined contribution retirement benefit schemes are charged as an expense as they fall due.
Crltical accounting estimates and judgements
In the application of the Charity's accounting policies, the Trustees are required to make judgem￿tS,
estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent
from other sources. The estimates and 3ssociated assumptions are based on historical experience and other
factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basi5. Revisions to accounting
estimates are recognised in the period in which the estimate is revised where the revision affects only that
period, or in the per iod of the revision and future periods where the revision affects both current and future
periods.
12-

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
NOTES TO THE FINANCIAL STATEMENTS ICONTINUEDJ
FOR THE YEAR ENDED 31 DECEMBER 2024
Doftatfons and le8a¢ies
Unrestrlrted Unrestricted
funds
funds
genernl
general
2024
2023
Donations and gifts
Other fundraising and 5pon50rship
6,492
7,576
11,603
5,636
Income from charitable activities
Unrestrirted
funds
2024
Unrestricted
funds
2023
Charltable attivtties
Grants and other income
89,674
103.667
Income from investments
Unrestrirted Unrestricted
fund5
funds
2024
2023
Interest receivable
3,233
653
13

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
NOTES TO THE FINANCIAL STATEMENTS (CONTINUEDI
FOR THE YEAR ENDED 31 DECEMBER 2024
Expendlture on charitable a¢tlvltles
Unrestrirted Unrestrlrted
funds
funds
2024
2023
Direct costs
Staff costs
Printing, postage and stationery
Recharges
Fundraising expense5
36,609
673
6,237
216
34,857
6,619
4,800
786
43,735
47,062
Share of support and governance costs (see note 7
Support
Governance
30,590
1,820
30.420
1.820
76.145
79,302
Analysis by fund
Unrestricted funds
76,145
79,302
Support costs allocated to activities
2024
2023
Staff costs
Rent
Sundries
Insurance
Consultancy fees
Professional fees
Governante costs
10,868
9,000
407
10,711
9,000
435
1,294
8,640
340
1,335
8.640
340
1,820
1,820
32,410
32,240
Analysed between:
Unrestricted f unds
32,410
32,240
14-

SYNCOPE TRusf AND REFLEX ANOXIC SEIZURES
NOTES TO THE FINANCIAL STATEMENTS {CONTINUED}
FOR THE YEAR EhlDED 31 DECEMBER 2024
Net movement In funds
2024
2023
The net movement in funds is stated after chargingllcreditingl:
Fees payable for the independent examination of the charity's ftnancial
statements
1,820
1,820
Employees
The average monthly number of employees during the year was:
2024
Number
2023
Number
Employment cost5
2024
2023
Wages 2 nd salaries
Social security costs
Other pension costs
31,774
3,756
1,079
39,060
3.361
816
36.609
43,308
There were no employees whose annual remuneration was more than £60,000.
10 Trustees fumuneration and benefits
There were no trustees, remuneratltsn or other benefits for the year ended 31 December 2024 nor for the
year ended 31 December 2023.
Trustees, expense5
There were no trustees, expenses paid for the year ended 31 December 2024 nor for the year ended 31
December 2023.
11 Taxatlon
The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.
15-

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED
FOR THE YEAR ENDED 31 DECEMBER 2024
12 Tangible fixed asset5
Ftxtures and
Cost
At l January 2024
15,895
At 31 December 2024
15,895
Depreciation and Impairment
At l January 2024
15.895
At 31 December 2024
15.895
Carrying amount
13 Debtors
2024
2023
Amounts falling due within one year:
Other debtors
Prepayments and accrued income
78,992
336
540.053
326
79,328
540,379
14 Creditors: amounts falling due within one year
2024
2023
Other creditors
Accruals and deferred income
1,778
1,680
1,976
1,680
3,458
3,656
15 Retirement benefit schemes
2024
2023
Defined contrlbution schemes
Charge to profit Of loss in respect of defined contributlon schemes
1,079
816
16.

SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES
NOTES TO THE FINANCIAL STATEMENTS {CONTINUED}
FOR THE YEAR ENDED 31 DECEMBER 2024
IS Retirement benefit schemes
Icontinuedl
The Charity operates a defined contribution pension scheme for all qualifying employees. The assets of the
scheme are held separately from those of the Charity in an independently administered fund.
16 Unrestricted funds
The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are
not subject to specific conditions by donors and grantors a5 to how they may be used. These include
designated funds which have been Set aside out of unrestricted funds by the trustees for specific purposes.
At l January
2024
Incoming
resources
Resources
expended
At31
December
2024
General fund5
605,320
106,975
176,1451
636.150
Previous year:
At l January
2023
In¢omlng
resources
Resource5
expended
At31
December
2023
General f unds
563,063
121.559
179,3021
605,320
17 Related party transartion5
There were no disclosable related party transactions during the year12023 ~ none).
18 Transactions with connected charlties
During the year, the charity was recharged £6,237 (2023: £4,800) by Arrhythmia Alliance IAAI, charity
number 1107496 for costs incurred on its behalf. Repaying of Services was apportioned from AA of £52,924
12023: £85,417}. At the year end, there was a balance due from this charity of £46,689 (2023- £411,315).
During the year, the charity recharge £25,560 {2023'. £25,790) for salary costs incurred on behalf of Atrial
Fibrillatron Association, charity number 1122442. At the year end, there was a balance due from this charity
of £25,560 {2023-, £121,7581.
17